TP53 Accumulation in Bladder Cancer Linked to Poor Prognosis
Author Information
Author(s): R Abdel-Fattah, C Challen, TRL Griffiths, MC Robinson, DE Neal, J Lunec
Primary Institution: University of Newcastle upon Tyne
Hypothesis
Is there a relationship between TP53 nuclear accumulation and mutations in bladder cancer, and how does this relate to patient survival?
Conclusion
TP53 accumulation often occurs without mutations and is associated with poor survival in bladder cancer patients.
Supporting Evidence
- TP53 nuclear accumulation was significantly associated with higher histological stage and grade.
- 33% of cases showed TP53 mutations, with clustering in exons 7 and 8.
- Patients with TP53 accumulation in more than 50% of tumor nuclei had decreased survival.
Takeaway
This study found that many bladder cancer patients have a lot of a protein called TP53, even when they don't have the usual mutations in the gene that makes it, and this can mean they might not live as long.
Methodology
Microdissection of paraffin-embedded sections and PCR-based direct DNA sequencing were used to analyze TP53 accumulation and mutations in bladder cancer samples.
Limitations
The study may not account for mutations outside of exons 4-9 of the TP53 gene.
Participant Demographics
Patients with transitional cell carcinoma of the bladder.
Statistical Information
P-Value
0.0003
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website